SiriusPoint sells ArmadaCare MGA to Ambac for $250M; expects pre-tax gain of ~$220-230M

SiriusPoint Ltd

Transaction values Armada at ~14x EBITDA; pro-forma tangible book value expected to rise ~10%.
SiriusPoint will continue capacity partnership with Armada until end of 2030.
Sale expected to close Q4 2025, subject to customary conditions and regulatory approvals.
CEO Scott Egan says sale unlocks off-balance sheet value; reaffirms 12-15% ROE target.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.